Inflammation in perivascular fat (PVAT) may play a role in atherosclerosis. 19, 20 Angiotensin (Ang) II and aldosterone induce oxidative stress and T lymphocyte and monocyte/ macrophage infiltration in PVAT. [21] [22] [23] It is unknown, however, whether ET-1 has similar effects.
ET-1 plasma levels are increased in patients with abdominal aortic aneurysms (AAAs). [24] [25] [26] Patients with larger AAAs displayed higher levels of ET-1. 25, 26 Accordingly, a role for ET-1 has been suggested in the development of AAAs in humans. Whether ET-1 overexpression indeed causes AAAs has not been demonstrated.
We hypothesized that ET-1-induced PVAT and vascular oxidative stress and inflammation contribute to the progression of atherosclerosis and increased incidence of AAAs. To test this hypothesis, we crossed eET-1 with Apoe −/− mice, to determine whether ET-1 overexpression exaggerates HFDinduced atherosclerosis in the latter, and establish whether this is associated with enhanced PVAT and vascular oxidative stress and inflammation, and whether increased incidence of AAAs will occur.
Materials and Methods
Materials and Methods are available in detail in the online-only Supplement.
Results

Physiological Parameters
HFD decreased body weight gain by 8%, 9%, 21%, and 24% in wild-type (WT), eET-1, Apoe −/− , and eET-1/Apoe −/− mice, respectively ( Table I in the online-only Data Supplement). This was not attributable to decreased growth because tibia length (TL) was similar in all groups. The eET-1/Apoe −/− mice presented a 20% increase in heart weight and heart weight/TL compared with WT. HFD decreased heart weight and heart weight/TL by ≈10% in WT and eET-1 mice and 25% in Apoe −/− and eET-1/Apoe −/− mice. HFD decreased kidney weight by 32% and 56% and kidney weight/TL by 31% and 37% in Apoe −/− and eET-1/Apoe −/− mice, respectively. HFD resulted in increased spleen weight and spleen weight/TL by 38% in eET-1 mice. Spleen weight/TL was increased by 9% in Apoe −/− mice, and spleen weight and spleen weight/TL were augmented by 14% in eET-1/Apoe −/− mice fed a HFD compared with regular chow.
As previously reported, 4,5 circulating ET-1 levels were >10-fold higher in eET-1 mice ( Figure 1A ) compared with WT mice fed a regular chow. The increase in plasma ET-1 was not affected by crossing eET-1 with Apoe −/− mice or by the diet. Systolic blood pressure (BP) and heart rate were not affected by genotype or diet ( Figure 1B ; Figure II in the online-only Data Supplement). However, when regular chow and HFD groups were combined, systolic BP was 10 to 15 mm Hg higher in eET-1, Apoe −/− , and eET-1/Apoe −/− compared with WT mice ( Figure 1B) . Plasma cholesterol was unaltered in eET-1 mice but was increased 2.6-and 3-fold in Apoe −/− and eET-1/Apoe −/− , respectively, compared with WT mice fed a regular chow ( Figure 1C ). HFD increased plasma cholesterol 1.5-and 1.8-fold in WT and eET-1 mice, respectively. As expected, HFD increased plasma cholesterol 7-fold in Apoe −/− mice, which was not affected by ET-1 overexpression.
Triglyceride levels were unaffected by ET-1 overexpression, Apoe knockout, or both in regular chow-fed animals ( Figure  III in the online-only Data Supplement). However, triglyceride levels were decreased ≈50% in WT and eET-1/Apoe −/− mice and tended to be lower in eET-1 and Apoe −/− mice in HFD-fed animals compared with regular chow. High-density lipoprotein (HDL) levels were unchanged by ET-1 overexpression, Apoe knockout, or both in regular chow-fed animals ( Figure 1D ). HDL levels were unaffected by the HFD in WT, eET-1, or Apoe −/− mice but were decreased 45% in eET-1/Apoe −/− mice.
ET-1 Overexpression Exacerbated HFD-Induced Atherosclerosis and Triggered AAA Formation in Apoe −/− Mice
HFD-induced atherosclerotic lesions were characterized in cyrosections of aortic sinus and 4 cryosections at 80-µm intervals of ascending aorta. No atherosclerotic lesions were detected in the aortic sinus and ascending aorta sections of WT or eET-1 mice (Figure 2A and 2B). Minor lipid deposition was observed in the aortic sinus of 2 of 9 WT and 3 of 9 eET-1 mice ( Figure IV in the online-only Data Supplement). Atherosclerotic lesions were detected in cryosections of aortic sinus and ascending aorta of HFD-fed Apoe −/− mice. HFDinduced an additional 2-and 6-fold increase in lesion size in the aortic sinus and ascending aorta, respectively, of eET-1/Apoe −/− mice compared with Apoe −/− mice. Atherosclerotic plaques in aortic arch sections of HFD-fed Apoe −/− and eET-1/Apoe −/− mice were further characterized by determining collagen distribution. Atherosclerotic plaques were observed in all 8 eET-1/Apoe −/− mice examined compared with 3 of 7 Apoe −/− mice (P<0.05). Plaques in eET-1/Apoe −/− mice contained necrotic cores surrounded by a fibrous cap ( Figure VI in the online-only Data Supplement). , systolic blood pressure (SBP; B), and plasma total cholesterol (C) and high-density lipoprotein (HDL; D) levels were determined in 16-week-old wild-type (WT), transgenic mice overexpressing ET-1 selectively in endothelium (eET-1), Apoe −/− , and eET1/Apoe −/− mice fed a high-fat diet (HFD) or regular chow (Ctrl) for 8 weeks starting at age 8 weeks. Values are mean±SEM, n=6 to 13 for A, 6 to 10 for B, and 7 to 12 for C and D. *P<0.05 and **P<0.001 vs WT on same diet, †P<0.05 and † †P<0.001 vs eET-1, ‡P<0.05 and ‡ ‡P<0.001 vs Apoe −/− on same diet and §P<0.05 and § §P<0.001 vs Ctrl.
AAAs were found at the suprarenal level in 8 of 21 eET-1/Apoe −/− mice fed a HFD ( Figure 3A ; Table 1 ). No AAAs were detected in the other groups fed a regular chow or HFD. All AAAs were associated with atherosclerosis plaques ( Figure 3A ). Aortic circumference at the suprarenal aortic level was 2-fold greater in eET-1/Apoe −/− mice with AAAs than in other groups fed a HFD ( Figure 3B ). Stretching and fragmentation of elastin was detected only in AAAs of eET-1/Apoe −/− mice ( Figure 4A ). The media collagen fraction was decreased 57% in HFD-fed Apoe −/− mice, which was not further changed by ET-1 overexpression ( Figure V in the online-only Data Supplement). Fibronectin expression in the media tended to decrease in HFD-fed Apoe −/− mice, and was decreased by 42% in HFD-fed eET-1/Apoe −/− mice ( Figure 4B ).
ET-1 Overexpression in HFD-Fed Apoe −/− Mice Exacerbated Superoxide Production in Ascending and AAAs
In HFD animals, reactive oxygen species (ROS) generation measured as dihydroethidium fluorescence tended to be higher in the media and PVAT of ascending and abdominal suprarenal aorta in eET-1 compared with WT mice ( Figure 5A and 5B). ROS production was increased 4.6-and 3.3-fold in the media and PVAT of ascending aorta, respectively, in Apoe −/− compared with WT mice ( Figure 5A ). ROS production was also detected in atherosclerotic plaques of Apoe −/− mice. The increase in ROS production was exaggerated 2.7-fold in the media and 1.9-fold in the PVAT and atherosclerotic lesions in eET-1/Apoe −/− compared with Apoe −/− mice. Similar changes in ROS generation were observed in abdominal suprarenal aorta ( Figure 5B ). ROS production was increased ≥6-fold in the media and PVAT in Apoe −/− compared with WT mice. This was further elevated 3.4-and 2.8-fold in the media and PVAT, respectively, in eET-1/Apoe −/− compared with Apoe −/− mice. Comparable levels of ROS were detected in atherosclerotic plaques at the level of abdominal suprarenal aorta and ascending aorta in eET-1/Apoe −/− mice ( Figure 5A and 5B).
ET-1 Overexpression in HFD-Fed Apoe −/− Mice Exacerbated Vascular Inflammation in Ascending and Abdominal Suprarenal Aorta
Monocyte/macrophage infiltration, measured in HFD-fed animals, was minimal in the ascending aorta of WT and eET-1 mice ( Figure 6A ). Monocyte/macrophage infiltration was detected in 2%, 8%, and 52% of the surface of media, PVAT, and atherosclerotic plaques, respectively, in Apoe −/− mice. In the ascending aorta of eET-1/Apoe −/− mice, monocyte/macrophage infiltration was further increased 5.2-and 8.3-fold in the media and PVAT, respectively, compared with Apoe −/− mice. The level of monocyte/macrophage infiltration in atherosclerotic lesions was similar in eET-1/Apoe −/− and Apoe −/− mice. In abdominal suprarenal aorta of Apoe −/− mice, monocyte/macrophage infiltration was detected in ≥12% of the surface of the media and PVAT ( Figure 6B ). This was further exaggerated 2.6-fold in the PVAT but not in the media of abdominal suprarenal aorta in eET-1/Apoe −/− mice compared with Apoe −/− mice. Similar levels of monocyte/macrophages were found in atherosclerotic lesions at the level of the abdominal suprarenal aorta and ascending aorta in eET-1/Apoe −/− mice ( Figure 6A and 6B).
CD4 + cells, measured in HFD-fed animals, were undetectable in ascending or abdominal suprarenal aorta of WT and eET-1 mice ( Table 2 ). Very few CD4 + cells were found in ascending aortic plaques of Apoe −/− mice. CD4 + infiltration was present more frequently in ascending and abdominal suprarenal aorta sections of eET-1/Apoe −/− mice. CD4 + cells were detected in ascending aorta sections of media in 3 of 6 and PVAT in 5 of 6 eET-1/Apoe −/− mice ( Figure 6C ; Table 2 ). CD4 + cell infiltration was also found in abdominal suprarenal aortic plaques of 4 of 6 eET-1/Apoe −/− mice ( Figure 6D ; Table 2 ). However, few CD4 + cells were detected in PVAT.
ET-1 Overexpression in HFD-Fed Apoe −/− Mice Exacerbated Spleen Proinflammatory Ly-6C hi Monocytes but Did Not Affect Plasma Cytokine Levels or T Cell Subsets
Plasma interleukin (IL)-6 was decreased by 61%, whereas tumor necrosis factor-α and monocyte chemotactic protein-1 tended to be lower, and IL-10 was unchanged in HFD-fed eET-1 compared with WT mice ( Figure VII in the onlineonly Data Supplement). Plasma tumor necrosis factor-α, IL-6, and monocyte chemotactic protein-1 levels were unchanged, whereas IL-10 tended to be increased in Apoe −/− compared with WT mice. ET-1 overexpression in Apoe −/− mice did not further alter the levels of IL-6, monocyte chemotactic protein-1, and IL-10, and tended to decrease tumor necrosis factor-α compared with Apoe −/− mice. The percentage of spleen CD3 + T cells tended to be decreased in Apoe −/− and eET-1/Apoe −/− compared with WT mice ( Figure VIII in the online-only Data Supplement). The percentage of spleen CD4 + T cells was unaffected by either ET-1 overexpression, Apoe knockout, or both. The percentage of spleen CD8 + T cells was decreased by 41% in Apoe −/− compared with WT mice, and tended to be increased in eET-1/Apoe −/− compared with Apoe −/− mice. The percentage of spleen anti-inflammatory CD4 + CD25 + FOXP3 + T regulatory cells was increased 2-fold in Apoe −/− and eET-1/Apoe −/− compared with WT mice. The percentage of spleen-activated CD4 + CD69 + T cells was increased 3.3-fold in Apoe −/− and eET-1/Apoe −/− compared with WT mice. The percentage of spleen-activated CD8 + CD69 + T cells was 2.4fold higher in Apoe −/− compared with WT mice, and tended to be further increased in eET-1/Apoe −/− mice. The percentage of spleen proinflammatory Ly-6C hi monocytes was increased 1.7-fold in Apoe −/− compared with WT mice, and was further increased 26% in eET-1/ Apoe −/− mice ( Figure IX in the online-only Data Supplement). ET-1 overexpression alone did not alter spleen T cell and monocyte subtype profiles.
ET-1 Overexpression Increased Matrix Metalloproteinase-2 Expression in Atherosclerotic Plaques
There was a 2-fold increase in matrix metalloproteinase-2 (MMP2) expression in atherosclerotic plaques of ascending aorta in eET-1 Apoe −/− compared with Apoe −/− mice (Figure X in the online-only Data Supplement).
Discussion
Our study extends our previous findings by demonstrating that increased expression of ET-1 in endothelium, in addition to exaggerating HFD-induced atherosclerosis, 18 triggers AAA formation in Apoe −/− mice, an atherosclerosis-prone model that resembles human disease. These phenomena were associated with decreased plasma HDL, elevated oxidative stress in the media, plaque, and PVAT, increased monocyte/macrophage infiltration primarily in the PVAT, CD4 + T cell infiltration in plaque and PVAT, and greater percentage of spleen proinflammatory Ly-6C hi monocytes. Our findings provide support to the hypothesis that ET-1 overexpression worsens the progression of atherosclerosis and contributes to the pathogenesis of AAAs via pro-oxidant and inflammatory mechanisms, and lowering of HDL.
Plasma ET immunoreactivity in patients with early and advanced atherosclerosis has been shown to be >2-fold higher than in healthy subjects, 12, 13 and has been correlated with the extent of atherosclerosis, indicating a possible role of ET-1 in atherogenesis. Animal studies have shown that ET-1 is increased in plasma and the vessel wall from Apoe −/−14, 16 and Ldlr −/− mice, 15 and in pigs 27 fed a HFD. Increased ET-1 expression in the vascular wall has also been associated with atherosclerosis development in 1-year-old Apoe −/− mice fed a regular chow. 26, 28 In the present study, 8 weeks of HFD induced an increase in plasma ET-1 levels in WT and Apoe −/− mice, but this was not sufficient to accelerate the development of atherosclerosis. The increase in plasma ET-1, however, did not reach the levels observed in previous pig and human studies. Consistent with our previous reports, both eET-1 and eET-1/Apoe −/− mice demonstrated 10-fold elevation in plasma ET-1. 4, 29 However, only eET-1/Apoe −/− mice presented advanced atherosclerosis. This suggests that increased ET-1 levels exaggerate the progression of atherosclerosis only in conditions predisposed toward the development of atherosclerosis. In agreement with this, it has been shown that ET-1 infusion inducing a similar increase in plasma levels caused worsening of the intimal hyperplastic response after mechanical injury in rats. 11 Interestingly, plasma ET immunoreactivity is higher in patients with AAAs and correlates with AAA size, suggesting a role for ET-1 in AAA pathogenesis. 25, 26 In this study, exaggeration of atherosclerosis in HFD-fed eET-1/Apoe −/− mice was accompanied by increased incidence of AAAs, indicating that elevated ET-1 levels could contribute to the development of AAAs in an atherosclerotic setting. We found a minor increase in total plasma cholesterol in HFD-fed WT and eET-1 mice. A similar increase in cholesterol levels was previously reported in WT C57BL/6 mice fed the same HFD as in this study for 12 or 18 weeks. 30, 31 It has also been shown that the increase in plasma cholesterol reaches a plateau after ≈2 weeks of HFD feeding. 31 Therefore, it is not surprising that the plasma cholesterol levels were increased in HFD-fed WT and eET-1 mice, which are on a C57BL/6 background. A large increase in plasma cholesterol was observed in HFD-fed Apoe −/− and eET-1/Apoe −/− mice. However, aggravation of atherosclerotic lesions and formation of AAAs occurred only in eET-1/Apoe −/− mice. This was accompanied by a decrease in plasma HDL. HDL levels are inversely correlated with the risk for coronary vascular disease. 32, 33 HDL mediates the reverse transport of cholesterol from the vasculature to the liver. 33 It has also been shown that, in addition to apolipoprotein A-I, HDL carry several proteins including α1-antitrypsin with anti-elastase activity, which can counteract the development of AAAs. 34 Therefore, it is plausible that ET-1 overexpression-induced decrease in HDL contributed to the enhanced damaging effects of increased plasma cholesterol on the induction of atherosclerosis and triggering of AAAs, as observed in HFD-fed eET-1/Apoe −/− mice. Further studies are required to determine the mechanisms by which ET-1 overexpression decreases plasma HDL. Previous studies have shown that the development of atherosclerosis in Apoe −/− mice can be accelerated by Ang II infusion 35 or deoxycorticosterone acetate-salt treatment. 36 Although Weiss et al 35 AAAs were observed in ≈40% of the eET-1/Apoe −/− mice fed a HFD, whereas none were detected in the other groups of mice. AAAs were observed at the suprarenal aortic level, as reported previously for Ang II-infused Apoe −/− mice. [37] [38] [39] As observed in humans, AAAs in HFD-fed eET-1/Apoe −/− mice were characterized by elastin breaks and flattening, and decreased media collagen fraction. 40 However, a decrease in media collagen fraction was also observed in HFD-fed Apoe −/− mice. Consequently, although collagen degradation lowers aortic tensile strength and therefore weakens the aortic wall, 41 it predisposes to but is not sufficient for AAA development in Apoe −/− mice. Incidentally, ET-1 overexpression in Apoe −/− mice caused a decrease in media fibronectin expression that could contribute to the development of AAAs by further weakening the aortic wall.
Table 2. CD4 + Cell Infiltration in Ascending and Abdominal Suprarenal Aortic Perivascular Fat and Atherosclerotic Plaques of Wild-Type, eET-1, Apoe −/− , and eET1/Apoe −/− Mice Fed a High-Fat Diet
Recently, Suen et al 42 reported that treatment with a mixed ET A/B receptor antagonist reduced Ang II-induced atherosclerosis in young (4 weeks) but not in old (6 months) Apoe −/− mice fed a Western-type diet, and failed to protect against Ang II-triggered AAAs. It is possible that blocking ET receptors only partially inhibits Ang II-mediated vascular inflammation and signaling pathways involved in the development of atherosclerosis and aneurysms. It is also possible that the increase in ET-1 expression might be suboptimal to induce AAAs in this model because Ang II did not cause a significant increase in plasma ET-1. Therefore, our findings suggest a novel mechanism of AAAs mediated by ET-1. The exact mechanism for aneurysm formation remains to be established. However, it is likely that oxidative stress and low-grade inflammation triggered by ET-1 overexpression 5 aggravate oxidative stress and inflammation already present in Apoe −/− mice, thereby playing a role in development of aneurysms.
We have previously reported that blood vessels in eET-1 mice are characterized by increased oxidative stress compared with WT mice. 4 Our current data show that ET-1 overexpression exaggerates ROS generation not only in the vascular wall but also in atherosclerotic plaques and PVAT in ascending aorta and AAAs of eET-1/Apoe −/− mice. This enhancement of oxidative stress could be attributable to increased activity of reduced nicotinamide adenine dinucleotide oxidase or uncoupling of endothelial NO synthase, or both. 43, 44 Kuhlencordt et al 45 previously showed that double Apoe and Nos3 knockout mice on a Western style diet exhibit increases in atherosclerotic lesions compared with Apoe −/− mice. In addition, Gao et al 46 demonstrated a role for tetrahydrobiopterin deficiency-induced endothelial NO synthase uncoupling causing •O 2 − production and reduced NO availability in AAA formation. Ang II-induced AAAs are increased in hyperphenylalaninemia (hph)-1 mice deficient in endothelial NO synthase cofactor tetrahydrobiopterin biosynthetic enzyme guanosine triphosphate cyclohydrolase 1, which can be prevented by restoring tetrahydrobiopterin levels by treatment with folic acid or endothelium-targeted dihydrofolate reductase gene therapy. These data are consistent with our findings, suggesting a key role of ET-1-induced oxidative stress in the development of atherosclerosis and AAA formation. In addition, our results suggest a participation of ET-1-induced ROS production by PVAT in atherosclerosis and AAA development.
The concept that atherosclerosis is an inflammatory disease is now well accepted. [47] [48] [49] [50] Monocyte/macrophage and T cell infiltration play roles in the pathogenesis of atherosclerosis 51 and AAA formation. 52 ET-1 can also be produced by macrophages, 53 which could further contribute to inflammation. Heavy ET-1 staining has been reported in foam cells within atherosclerotic lesions, and in vascular smooth muscle cells of the intima and media. 28 Here, ET-1 overexpression exaggerated monocyte/macrophage infiltration primarily in the PVAT of ascending aorta and AAAs in eET-1/Apoe −/− compared with Apoe −/− mice. However, monocyte/macrophage infiltration was equally high in plaques from eET-1/Apoe −/− and Apoe −/− mice. Because atherosclerotic plaques are larger in eET-1/Apoe −/− compared with Apoe −/− mice, and the cell infiltration is expressed as percentage of total surface, these data can also be interpreted as eET-1/Apoe −/− mice having more atherosclerotic plaque monocytes/macrophages. Interestingly, ET-1 overexpression exaggerated the increase in the percentage of spleen proinflammatory Ly-6C hi monocytes in Apoe −/− mice, suggesting that there is an increase in circulating proinflammatory Ly-6C hi monocytes that can contribute to the increase in monocyte/macrophage infiltration in the PVAT and, hence, to the development of atherosclerotic plaques. It should be noted that the monocyte subtype profile was unchanged by ET-1 overexpression in absence of Apoe knockout. MMP2, which could be secreted by macrophages, was higher in plaques from eET-1/Apoe −/− than from Apoe −/− mice. The increase in MMP2 could contribute to plaque development and rupture, and AAA formation. However, the mechanisms by which ET-1 overexpression increases MMP2 expression in the plaques are unknown and could be mediated in part by monocytes and macrophages. It has been shown that the severity of atherosclerosis is reduced in Apoe −/− mice that are lacking functional monocyte/macrophages 54 or are deficient in MMP2. 55 Recently, we reported that ET-1 overexpression-induced vascular remodeling and oxidative stress, which is associated with monocyte/macrophage infiltration in the adventitia and PVAT, is prevented by crossing eET-1 with mice carrying an osteopetrotic mutation in the macrophage colony-stimulating factor (Csf1 Op/+ ) gene. 29 Increased expression of ET-1 in endothelial cells of eET-1/Apoe −/− mice could act in paracrine fashion to stimulate the production of proinflammatory monocytes in the periphery, increase the recruitment of monocytes to atherosclerotic plaques, and promote the differentiation of monocytes into macrophages. Whether ET-1 overexpression directly increases the expression of MMP2 in macrophages remains to be determined.
In this study, the eET-1 mice did not present signs of systemic inflammation because plasma cytokines and spleen T cells and monocyte subtype profiles were unaltered. Apoe −/− mice fed a HFD for 8 weeks presented low levels of systemic inflammatory mediators. Plasma tumor necrosis factor-α, IL-6, monocyte chemotactic protein-1, and IL-10 levels were unchanged, and the percentage of spleen-activated CD4 + CD69 + , CD8 + CD69 + T cells, and CD4 + CD25 + FOXP3 + T regulatory cells, which are suppressor T cells, were elevated. The increase in T regulatory cells could probably be a compensatory mechanism counteracting the increase in activated T cells. ET-1 overexpression did not change the plasma cytokine levels and the T cell profile and, therefore, did not alter the systemic inflammation in Apoe −/− mice. CD4 + T cell infiltration was barely detectable in atherosclerotic plaques of Apoe −/− mice. ET-1 overexpression induced CD4 + T cell infiltration in atherosclerotic plaques and PVAT in ascending aorta, and in plaques in AAAs of eET-1/Apoe −/− mice on HFD. CD8 + T cells could not be detected in media, atherosclerotic plaque or PVAT of Apoe −/− or eET-1/Apoe −/− mice (data not shown). Interestingly, crossing Apoe −/− mice with severe combined immunodeficiency (Scid) mice lacking T and B cells has been shown to reduce atherosclerosis. Adoptive transfer of CD4 + T cells abolished this protection and increased atherosclerotic lesions in immunodeficient Apoe −/− mice. 56 Therefore, previous data are consistent with our findings and suggest an important role for ET-1-induced infiltration of monocyte/macrophages and CD4 + T cells in development of atherosclerosis and AAA formation. In addition, our results indicate an important role for ET-1-induced inflammatory cell infiltration in PVAT for both atherosclerosis and AAA development. However, the mechanisms of ET-1-induced T cell infiltration remain to be determined.
There is evidence that PVAT plays a role in atherosclerosis. 19, 20 In humans and mice, PVAT presents a higher inflammatory state compared with subcutaneous and epididymal fat. 57 HFD induced ROS production in PVAT, which caused endothelial dysfunction. 58 PVAT is a source of vascular inflammatory cells that play a role in hypertension and vascular damage. 22 PVAT surrounding atherosclerotic aorta has chemotactic properties through secretion of cytokines, thereby attracting macrophages and T cells. 59 Accumulation of macrophages and T cells at the interface between PVAT and adventitia of human atherosclerotic aorta has been previously reported. In Apoe −/− mice fed HFD, PVAT transplantation next to the common carotid artery, a site normally devoid of atherosclerotic lesions, impairs vascular relaxation and causes local formation of an atherosclerotic plaque. 60 So far, there has been no evidence of a role of PVAT in AAA formation. However, the previously cited results are consistent with our finding that increased ET-1 enhances ROS production and monocyte/macrophage and CD4 + T cell infiltration in PVAT, which then plays a role in progression of atherosclerosis and in AAA formation.
Recently, we showed that there was an increase in expression of genes associated with lipid biogenesis, including elongation of very long chain fatty acids family member 6 (Elovl6) that is responsible for the final step in saturated fatty acid synthesis, which could lead to excess accumulation of lipids within the vascular wall and, hence, contribute to vascular remodeling, endothelial dysfunction, and development of atherosclerosis. 18 Saito et al 61 have suggested a role for ELOVL6-induced elongation of saturated and monounsaturated fatty acids in foam cell formation and atherosclerosis progression. In their study, Western diet-induced atherosclerotic lesions and monocyte/macrophage infiltration were reduced in irradiated Ldlr −/− mice transplanted with bone marrow cells from Elovl6 −/− versus cells from WT mice. It is possible that higher levels of ET-1 might increase the expression of Elovl6 in macrophages resulting in exaggeration of foam cell formation, progression of atherosclerosis, and development of AAA formation.
A limitation of the present study is that the eET-1 mice presented a greater increase in plasma levels of ET-1 than that observed in humans with atherosclerosis or aneurysms. However, by achieving greater increase in ET-1 expression, and thereby exaggerating the activity of a biological system such as ET-1, we were able to reveal the underlying pathophysiological mechanisms by which ET-1 contributes to the development of atherosclerosis and aneurysms. Nevertheless, additional studies might be necessary to confirm the importance for humans of the present findings.
Conclusions and Perspectives
We have demonstrated that ET-1 overexpression exerts a potent proatherogenic effect and triggers AAA formation in Apoe −/− mice on a HFD, possibly through pro-oxidant and inflammatory mechanisms and decrease in HDL. We also suggest that PVAT plays a prominent role. Clinically, our results underscore the importance of ET-1 in human atherosclerosis and AAA formation. ET A or ET A/B receptor blockers and ET converting enzyme inhibitors could be potential pharmacological candidates for treatment of atherosclerosis and prevention of growth of AAAs. In support, Yoon et al 62 have recently showed that long-term ET A receptor blocker treatment attenuates the progression of coronary plaques in patients with early atherosclerosis.
